Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trialDongsheng Wang, Xiaoling Xu, Zhen Peng et al.|Frontiers of Medicine|2021Cited by 80
<p>p70S6K Promotes Acquired Resistance of Erlotinib Through Induction of Epithelial-Mesenchymal Transition in Non-Small Cell Lung Carcinoma</p>Min Li, Xuerong Wang|OncoTargets and Therapy|2020Cited by 6